BrainDx was formed by internationally recognized Neurophysiological researchers and clinicians for the purpose of making readily available the knowledge derived from the evolution of the field of quantitative electrophysiology, translating it from the research laboratory to clinical practice.Fundamental to this effort was the research and development conducted at the Brain Research Laboratories of New York University School of Medicine. The outcome of this research has been presented at innumerable professional society meetings internationally, published extensively and widely across disciplines, in peer-reviewed journals and textbooks, and has been applied in many areas of health care, instrumentation, education, and forensics.


BrainDx has developed a modular system that allows the client to evaluate brain function on many levels of analysis which can assist in the classification of an individual in terms of psychiatric disorders and neurological conditions. Using 3-D source localization methods, the mathematically most probable underlying sources of the scalp recorded data can be identified, and used to further understand the pathophysiology of the disorder, and thereby aid in optimization and evaluation of therapeutic techniques including medications. The BrainDx technology produces an interpretive report that can be used by clinicians to document neurofunctional status related to an individual’s behavior and performance capacities.


Part of the report generation process includes comparing the results of a patient’s brain functional profile to a database of age matched normal individuals. Then, incorporating information from the patient’s history, statistical comparisons are made to the appropriate clinical databases comparing the QEEG profile of the individual patient to those with known disorders, assessing the probability that the patient statistically resembled such patients, and thereby assisting the diagnostic process. Further, clinical guidelines for therapeutic intervention can be offered based on these profiles to assist the end user with the task of prioritizing treatment options.


For example, if a patient presents with general complaints about memory loss or says that their work is not going well, the BrainDx system can objectively evaluate their brain function relative to age expected normal values, and suggest the statistical probability that the EEG profile seen in this patient is consistent with that of a patient with dementia, rather than a patient with clinical depression. A non-invasive, 20-30 minute QEEG brain evaluation can generate with statistical accuracy the probability that a patient with particular symptoms matches others in the database with similar symptoms and an objective diagnosis. For example, in the case of pediatric concerns, differentiate Learning Disorder (LD) from Normal or Attention-Deficit/Hyperactivity Disorder (ADHD) from Autism Spectrum Disorder (ASD). ,etc. In addition BrainDx can also provide the ability to evaluate brain function,when the patient is in two different states; a quantitative assessment of the change in brain function between the two states, for example, on and off a medication.


These software tools are provided to operate on different platforms and made affordable for a variety of clinical purposes as well as a tool for research programs worldwide. Get answers you are seeking from your EEG data in seconds and explore the universe of questions regarding brain-behavior relationships.